Quick Answer
Aura Biosciences, Inc. reported Operating Income of -$112.79 million for fiscal year 2025.
Aura Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$112.79M | -17.3% |
| 2024 | -$96.12M | -13.1% |
| 2023 | -$84.99M | -41.0% |
| 2022 | -$60.30M | -71.0% |
| 2021 | -$35.25M | -58.7% |
| 2020 | -$22.21M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.91M | -20.1% | +2.5% |
| June 30, 2025 | -$28.61M | -25.7% | +1.5% |
| March 31, 2025 | -$29.04M | -30.1% | -25.0% |
| September 30, 2024 | -$23.23M | -13.4% | -2.1% |
| June 30, 2024 | -$22.76M | -12.3% | -2.0% |
| March 31, 2024 | -$22.31M | -14.8% | -8.9% |
| September 30, 2023 | -$20.49M | -27.6% | -1.0% |
| June 30, 2023 | -$20.28M | -46.8% | -4.3% |
- Aura Biosciences, Inc. showed a decrease of -17.3% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Aura Biosciences, Inc.’s operating income has declined by 407.9% (from -$22.21 million to -$112.79 million).
- The most recent figure is from Aura Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: